Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Treatment of functional mitral regurgitation by percutaneous annuloplasty using the Carillon Mitral Contour System—Currently available data state

Treatment of functional mitral regurgitation by percutaneous annuloplasty using the Carillon... Received: 16 November 2016 Revised: 16 January 2017 Accepted: 18 January 2017 | | DOI 10.1111/joic.12370 STRUCTURAL HEART DISEASE Treatment of functional mitral regurgitation by percutaneous annuloplasty using the Carillon Mitral Contour System—Currently available data state Dorothee H. L. Bail MD, PhD Karl-Olga-Hospital, Stuttgart, Germany OBJECTIVE: The purpose of this study is to provide a systematic review of currently available *Correspondence data about the percutaneous trans-coronary-venous mitral annuloplasty with the Carillon Dorothee H. L. Bail, MD, PhD, Karl-Olga-Hospital GmbH, Hackstr. 61, 70190 Mitral Contour System. Stuttgart, Germany. METHOD: A systematic literature search was conducted using the common medical and Email: dorotheebail@t-online.de scientific databases. The documented parameters included among others grade of mitral regurgitation (MR), vena contracta (VC), effective regurgitant orifice area (EROA), 6 minute- walk-test (6MWT), NYHA-classification, and Quality of Life (QoL) at baseline, 30 days and in the long-term follow-up. RESULTS: The exact total number of successfully implantations with available data remains unclear because so many publications are either of the same institution or study group, or they present overlapping results. Reduction of functional mitral regurgitation (FMR) was associated with significant inverse left-ventricular (LV)) remodeling, improvement in 6MWT, QoL and NYHA-class during the 12-month follow-up. In almost half http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Interventional Cardiology Wiley

Treatment of functional mitral regurgitation by percutaneous annuloplasty using the Carillon Mitral Contour System—Currently available data state

Download PDF
7 pages

Loading next page...
 
/lp/wiley/treatment-of-functional-mitral-regurgitation-by-percutaneous-EapS38ye17

References (44)

Publisher
Wiley
Copyright
© 2017 Wiley Periodicals, Inc.
ISSN
0896-4327
eISSN
1540-8183
DOI
10.1111/joic.12370
pmid
28247436
Publisher site
See Article on Publisher Site

Abstract

Received: 16 November 2016 Revised: 16 January 2017 Accepted: 18 January 2017 | | DOI 10.1111/joic.12370 STRUCTURAL HEART DISEASE Treatment of functional mitral regurgitation by percutaneous annuloplasty using the Carillon Mitral Contour System—Currently available data state Dorothee H. L. Bail MD, PhD Karl-Olga-Hospital, Stuttgart, Germany OBJECTIVE: The purpose of this study is to provide a systematic review of currently available *Correspondence data about the percutaneous trans-coronary-venous mitral annuloplasty with the Carillon Dorothee H. L. Bail, MD, PhD, Karl-Olga-Hospital GmbH, Hackstr. 61, 70190 Mitral Contour System. Stuttgart, Germany. METHOD: A systematic literature search was conducted using the common medical and Email: dorotheebail@t-online.de scientific databases. The documented parameters included among others grade of mitral regurgitation (MR), vena contracta (VC), effective regurgitant orifice area (EROA), 6 minute- walk-test (6MWT), NYHA-classification, and Quality of Life (QoL) at baseline, 30 days and in the long-term follow-up. RESULTS: The exact total number of successfully implantations with available data remains unclear because so many publications are either of the same institution or study group, or they present overlapping results. Reduction of functional mitral regurgitation (FMR) was associated with significant inverse left-ventricular (LV)) remodeling, improvement in 6MWT, QoL and NYHA-class during the 12-month follow-up. In almost half

Journal

Journal of Interventional Cardiology – Wiley

Published: Apr 1, 2017

Keywords: ; ;

There are no references for this article.